知镜 Cognispect · 医学文献与研究工作台

TWEAK signaling drives the transition from psoriasis to atopic dermatitis-like inflammation in paradoxical eczema.

Marella S, Bogle R, Zhang H, Fox J, Kirma J, Xing X, Klein B, van Drongelen V, Feister Z, Zagairy F, Hamed M, Liaks M, Ziv M, Jiang R, Dey P, Kahlenberg JM, Billi AC, Tsoi LC, Gudjonsson JE, Barak EC.
Science translational medicine · 2026-11-04 · PMID 42981427

文献摘要

Targeted biologics have transformed the treatment of inflammatory skin diseases such as plaque psoriasis. However, some patients with psoriasis paradoxically develop eczematous skin reactions after therapy targeting tumor necrosis factor (TNF), interleukin-17 (IL-17), or IL-23. Although paradoxical eczema (PE) resembles atopic dermatitis (AD) clinically and histologically, the molecular mechanisms that drive its development remain poorly understood. Here, we generated high-resolution cellular and spatial maps of human skin using single-cell RNA sequencing, spatial transcriptomics, immunohistochemistry, and in vitro assays, profiling lesional biopsies from patients with PE ( n = 8 donors), alongside healthy control, psoriasis, and AD skin ( n = 4 donors per group). In PE, we identified distinct transcriptional changes characterized by myeloid and T cell expansion and an altered keratinocyte phenotype shaped by TNF-like weak inducer of apoptosis (TWEAK; encoded by TNFSF12 ) signaling through its receptor TNFRSF12A , confirmed at the protein level by immunohistochemistry. To define the underlying mechanism, we stimulated immortalized (N-TERT) and primary human keratinocytes and found that TWEAK acted together with IL-13 to drive a T helper 2- and type I interferon-polarized epithelial program that partially recapitulated the keratinocyte signature of PE lesions. We validated key target genes by quantitative polymerase chain reaction in primary keratinocytes. In THP-1 cells and primary human CD14 + monocytes, anti-TNF treatment induced TWEAK expression, suggesting a compensatory inflammatory circuit. Together, these findings identify the TWEAK-IL-13 axis as a key driver of PE and suggest how cytokine blockade may reshape cutaneous immune responses.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。